AAAAAA

   
Results: 1-11 |
Results: 11

Authors: DOBRILLA G DIMATTEO G DODERO M FRATTON A IAQUINTO G LORIGA P MARCHI S MARZIO L MURATORI R PACINI D SAGGIORO A SAVARINO V SPINELLI P ZAMBONI G FINA P TOSATTO R OLIVIERI A
Citation: G. Dobrilla et al., RANITIDINE BISMUTH CITRATE WITH EITHER CLARITHROMYCIN 1 G DAY OR 1.5 G/DAY IS EQUALLY EFFECTIVE IN THE ERADICATION OF HELICOBACTER-PYLORI AND HEALING OF DUODENAL-ULCER/, Alimentary pharmacology & therapeutics, 12(1), 1998, pp. 63-68

Authors: LOPERFIDO S ANGELINI G BENEDETTI G CHILOVI F COSTAN F DEBERARDINIS F DEBERNARDIN M EDERLE A FINA P FRATTON A
Citation: S. Loperfido et al., MAJOR EARLY COMPLICATIONS FROM DIAGNOSTIC AND THERAPEUTIC ERCP - A PROSPECTIVE MULTICENTER STUDY, Gastrointestinal endoscopy, 48(1), 1998, pp. 1-10

Authors: GRIDELLI C IANNIELLO GP AMBROSINI G MUSTACCHI G PEDICINI T FARRIS A IACOBELLI S ROSSI G MORETTI G ANGELINI F DELENA M DICARLO A BONSIGNORI M SABBATINI R CATALANO G ROSSI A OLIVIERI A FINA P BIANCO AR
Citation: C. Gridelli et al., A MULTICENTER, DOUBLE-BLIND, RANDOMIZED TRIAL COMPARING ONDANSETRON VERSUS ONDANSETRON PLUS DEXAMETHASONE IN THE PROPHYLAXIS OF CISPLATIN-INDUCED DELAYED EMESIS, International journal of oncology, 10(2), 1997, pp. 395-400

Authors: CORSI M FINA P TRIST DG
Citation: M. Corsi et al., CO-AGONISM IN DRUG-RECEPTOR INTERACTION - ILLUSTRATED BY THE NMDA RECEPTORS, Trends in pharmacological sciences, 17(6), 1996, pp. 220-222

Authors: CAFFO O DOGLIONI C VERONESE S BONZANINI M MARCHETTI A BUTTITTA F FINA P LEEK R MORELLI L DALLAPALMA P HARRIS AL BARBARESCHI M
Citation: O. Caffo et al., PROGNOSTIC VALUE OF P21(WAF1) AND P53 EXPRESSION IN BREAST-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY IN 261 PATIENTS WITH LONG-TERM FOLLOW-UP, Clinical cancer research, 2(9), 1996, pp. 1591-1599

Authors: BARBARESCHI M CAFFO O VERONESE S LEEK RD FINA P FOX S BONZANINI M GIRLANDO S MORELLI L ECCHER C PEZZELLA F DOGLIONI C PALMA PD HARRIS A
Citation: M. Barbareschi et al., BCL-2 AND P53 EXPRESSION IN NODE-NEGATIVE BREAST-CARCINOMA - A STUDY WITH LONG-TERM FOLLOW-UP, Human pathology, 27(11), 1996, pp. 1149-1155

Authors: BARBARESCHI M CAFFO O DOGLIONI C FINA P MARCHETTI A BUTTITTA F LEEK R MORELLI L LEONARDI E BEVILACQUA G DALLAPALMA P HARRIS AL
Citation: M. Barbareschi et al., P21(WAF1) IMMUNOHISTOCHEMICAL EXPRESSION IN BREAST-CARCINOMA - CORRELATIONS WITH CLINICOPATHOLOGICAL DATA, ESTROGEN-RECEPTOR STATUS, MIB1 EXPRESSION, P53 GENE AND PROTEIN ALTERATIONS AND RELAPSE-FREE SURVIVAL, British Journal of Cancer, 74(2), 1996, pp. 208-215

Authors: BARBARESCHI M WEIDNER N GASPARINI G MORELLI L FORTI S ECCHER C FINA P CAFFO O LEONARDI E MAURI F BEVILACQUA P PALMA PD
Citation: M. Barbareschi et al., MICROVESSEL DENSITY QUANTIFICATION IN BREAST CARCINOMAS - ASSESSMENT BY LIGHT-MICROSCOPY VS A COMPUTER-AIDED IMAGE-ANALYSIS SYSTEM, Applied immunohistochemistry, 3(2), 1995, pp. 75-84

Authors: NICOLATO A GEROSA MA FINA P IUZZOLINO P GIORGIUTTI F BRICOLO A
Citation: A. Nicolato et al., PROGNOSTIC FACTORS IN LOW-GRADE SUPRATENTORIAL ASTROCYTOMAS - A UNI-MULTIVARIATE STATISTICAL-ANALYSIS IN 76 SURGICALLY TREATED ADULT PATIENTS, Surgical neurology, 44(3), 1995, pp. 208-221

Authors: MARCHETTI A BUTTITTA F GIRLANDO S DALLAPALMA P PELLEGRINI S FINA P DOGLIONI C BEVILACQUA G BARBARESCHI M
Citation: A. Marchetti et al., MDM2 GENE ALTERATIONS AND MDM2 PROTEIN EXPRESSION IN BREAST CARCINOMAS, Journal of pathology, 175(1), 1995, pp. 31-38

Authors: IUZZOLINO P GHIMENTON C NICOLATO A GIORGIUTTI F FINA P DOGLIONI C BARBARESCHI M
Citation: P. Iuzzolino et al., P53 PROTEIN IN LOW-GRADE ASTROCYTOMAS - A STUDY WITH LONG-TERM FOLLOW-UP, British Journal of Cancer, 69(3), 1994, pp. 586-591
Risultati: 1-11 |